Hostname: page-component-745bb68f8f-l4dxg Total loading time: 0 Render date: 2025-01-26T18:09:17.387Z Has data issue: false hasContentIssue false
  • English
  • Français

Diversity of ARSACS Mutations in French-Canadians

Published online by Cambridge University Press:  23 September 2014

I. Thiffault ,
M.J. Dicaire ,
M. Tetreault ,
K.N. Huang ,
J. Demers-Lamarche ,
G. Bernard ,
A. Duquette ,
R. Larivière ,
K. Gehring  and
A. Montpetit
...Show all authors
I. Thiffault
Affiliation:
Neurogenetics of Motion Laboratory, Montreal
M.J. Dicaire
Affiliation:
Neurogenetics of Motion Laboratory, Montreal Fondation de l'Ataxie de Charlevoix-Saguenay-CIHR Emerging Team on rare diseases
M. Tetreault
Affiliation:
Neurogenetics of Motion Laboratory, Montreal
K.N. Huang
Affiliation:
Neurogenetics of Motion Laboratory, Montreal
J. Demers-Lamarche
Affiliation:
Neurogenetics of Motion Laboratory, Montreal
G. Bernard
Affiliation:
Neurogenetics of Motion Laboratory, Montreal
A. Duquette
Affiliation:
Neurogenetics of Motion Laboratory, Montreal
R. Larivière
Affiliation:
Neurogenetics of Motion Laboratory, Montreal Fondation de l'Ataxie de Charlevoix-Saguenay-CIHR Emerging Team on rare diseases
K. Gehring
Affiliation:
Neuromuscular Group, Department of Biochemistry, Montreal Fondation de l'Ataxie de Charlevoix-Saguenay-CIHR Emerging Team on rare diseases
A. Montpetit
Affiliation:
Genome Quebec Innovation Centre, Montreal
P.S. McPherson
Affiliation:
Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University Fondation de l'Ataxie de Charlevoix-Saguenay-CIHR Emerging Team on rare diseases
A. Richter
Affiliation:
CHU Sainte-Justine, Université de Montréal, Montréal
L. Montermini
Affiliation:
CHU Sainte-Justine, Université de Montréal, Montréal
J. Mercier
Affiliation:
CHU Sainte-Justine, Université de Montréal, Montréal Fondation de l'Ataxie de Charlevoix-Saguenay-CIHR Emerging Team on rare diseases
G.A. Mitchell
Affiliation:
CHU Sainte-Justine, Université de Montréal, Montréal
N. Dupré
Affiliation:
Département des sciences neurologiques, CHUQ – Hôpital de l'Enfant-Jésus, Université Laval, Québec
C. Prévost
Affiliation:
Clinique des Maladies Neuromusculaires, CSSS de Jonquière, Saguenay
J.P. Bouchard
Affiliation:
Département des sciences neurologiques, CHUQ – Hôpital de l'Enfant-Jésus, Université Laval, Québec Fondation de l'Ataxie de Charlevoix-Saguenay-CIHR Emerging Team on rare diseases
J. Mathieu
Affiliation:
Clinique des Maladies Neuromusculaires, CSSS de Jonquière, Saguenay
B. Brais*
Affiliation:
Neurogenetics of Motion Laboratory, Montreal Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University CHU Sainte-Justine, Université de Montréal, Montréal Clinique des Maladies Neuromusculaires, CSSS de Jonquière, Saguenay Fondation de l'Ataxie de Charlevoix-Saguenay-CIHR Emerging Team on rare diseases
*
Neurogenetics of Motion Laboratory, Neuromuscular Group, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, Quebec, H3A 2B4, Canada Email: Bernard.Brais@mcgill.ca
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

The growing number of spastic ataxia of Charlevoix-Saguenay (SACS) gene mutations reported worldwide has broadened the clinical phenotype of autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). The identification of Quebec ARSACS cases without two known SACS mutation led to the development of a multi-modal genomic strategy to uncover mutations in this large gene and explore phenotype variability.

Methods:

Search for SACS mutations by combining various methods on 20 cases with a classical French-Canadian ARSACS phenotype without two mutations and a group of 104 sporadic or recessive spastic ataxia cases of unknown cause. Western blot on lymphoblast protein from cases with different genotypes was probed to establish if they still expressed sacsin.

Results:

A total of 12 mutations, including 7 novels, were uncovered in Quebec ARSACS cases. The screening of 104 spastic ataxia cases of unknown cause for 98 SACS mutations did not uncover carriers of two mutations. Compounds heterozygotes for one missense SACS mutation were found to minimally express sacsin.

Conclusions:

The large number of SACS mutations present even in Quebec suggests that the size of the gene alone may explain the great genotypic diversity. This study does not support an expanding ARSACS phenotype in the French-Canadian population. Most mutations lead to loss of function, though phenotypic variability in other populations may reflect partial loss of function with preservation of some sacsin expression. Our results also highlight the challenge of SACS mutation screening and the necessity to develop new generation sequencing methods to ensure low cost complete gene sequencing.

Type
Original Article
Information
Canadian Journal of Neurological Sciences , Volume 40 , Issue 1 , January 2013 , pp. 61 - 66
Copyright
Copyright © The Canadian Journal of Neurological 2013

References

1. Dupré, N, Bouchard, JP, Brais, B, Rouleau, GA. Hereditary ataxia, spastic paraparesis and neuropathy in the French-Canadian population. Can J Neurol Sci. 2006;33:149–57.CrossRefGoogle ScholarPubMed
2. Engert, JC, Berube, P, Mercier, J, et al. ARSACS, a spastic ataxia common in northeastern Quebec, is caused by mutations in a new gene encoding an 11.5-kb ORF. Nat Genet. 2000;24:120–5.CrossRefGoogle Scholar
3. De Braekeleer, M, Giasson, F, Mathieu, J, Roy, M, Bouchard, JP, Morgan, K. Genetic epidemiology of autosomal recessive spastic ataxia of Charlevoix-Saguenay in northeastern Quebec. Genet Epidemiol. 1993;10:17–25.CrossRefGoogle ScholarPubMed
4. Vermeer, S, Meijer, RP, Pijl, BJ, et al. ARSACS in the Dutch population: a frequent cause of early-onset cerebellar ataxia. Neurogenetics. 2008;9:207–14.CrossRefGoogle ScholarPubMed
5. Bouchard, JP, Barbeau, A, Bouchard, R, Bouchard, RW. Autosomal recessive spastic ataxia of Charlevoix-Saguenay. Can J Neurol Sci. 1978;5:61–9.CrossRefGoogle ScholarPubMed
6. Bouchard, JP, Barbeau, A, Bouchard, R, Bouchard, RW. Electromyography and nerve conduction studies in Friedreich's ataxia and autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). Can J Neurol Sci. 1979;6:185–9.CrossRefGoogle ScholarPubMed
7. Okawa, S, Sugawara, M, Watanabe, S, Imota, T, Toyoshima, I. A novel sacsin mutation in a Japanese woman showing clinical uniformity of autosomal recessive spastic ataxia of Charlevoix-Saguenay. J Neurol Neurosurg Psychiatry. 2006;77:280–2.CrossRefGoogle Scholar
8. Desserre, J, Devos, D, Sautiere, BG, et al. Thickening of peripapillar retinal fibers for the diagnosis of autosomal recessive spastic ataxia of Charlevoix-Saguenay. Cerebellum. 2011 Dec;10(4):758–62.CrossRefGoogle ScholarPubMed
9. Baets, J, Deconinck, T, Smets, K, et al. Mutations in SACS cause atypical and late-onset forms of ARSACS. Neurology. 2010;75:1181–8.CrossRefGoogle ScholarPubMed
10. Wang, K, Li, M, Hadley, D, et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. 2007;17:1665–74.CrossRefGoogle ScholarPubMed
11. Guernsey, DL, Dube, MP, Jiang, H, et al. Novel mutations in the sacsin gene in ataxia patients from Maritime Canada. J Neurol Sci. 2010;288:79–87.CrossRefGoogle ScholarPubMed
12. McMillan, HJ, Carter, MT, Jacob, PJ, Laffan, EE, O’Connor, MD, Boycott, KM. Homozygous contiguous gene deletion of 13q12 causing LGMD2C and ARSACS in the same patient. Muscle Nerve. 2009;39:396–9.CrossRefGoogle ScholarPubMed
13. Breckpot, J, Takiyama, Y, Thienpont, B, et al. A novel genomic disorder: a deletion of the SACS gene leading to spastic ataxia of Charlevoix-Saguenay. Eur J Hum Genet. 2008;16:1050–4.CrossRefGoogle ScholarPubMed
14. Terracciano, A, Casali, C, Grieco, GS, et al. An inherited large-scale rearrangement in SACS associated with spastic ataxia and hearing loss. Neurogenetics. 2009;10:151–5.CrossRefGoogle ScholarPubMed
15. Vermeer, S, Meijer, RPP, Hofste, TGJ, et al. Design and validation of a conformation sensitive capillary electrophoresis -based mutation scanning system and automated data analysis of the more than 15 kbp-spanning coding sequence of the SACS Gene. J Mol Diagn. 2009;11:514–23.CrossRefGoogle ScholarPubMed
16. Duquette, A, Roddier, K, McNabb-Baltar, J, et al. Mutations in senataxin responsible for Quebec cluster of ataxia with neuropathy. Ann Neurol. 2005 Mar;57(3):408–14.CrossRefGoogle ScholarPubMed
17. Bayat, V, Thiffault, I, Jaiswal, M, et al. Mutations in the mitochondrial methionyl-tRNA synthetase cause a neurodegenerative phenotype in flies and a recessive ataxia (ARSAL) in humans. PLoS Biol. 2012;10:e1001288.CrossRefGoogle Scholar
18. Thiffault, I, Rioux, MF, Tetreault, M, et al. A new autosomal recessive spastic ataxia associated with frequent white matter changes maps to 2q33-34. Brain. 2006;129:2332–40.CrossRefGoogle ScholarPubMed
19. Dupré, N, Gros-Louis, F, Chrestian, N, et al. Clinical and genetic study of autosomal recessive cerebellar ataxia type 1. Ann Neurol. 2007;62:93–8.CrossRefGoogle ScholarPubMed
20. Gros-Louis, F, Dupré, N, Dion, P, et al. Mutations in SYNE1 lead to a newly discovered form of autosomal recessive cerebellar ataxia. Nat Genet. 2007 Jan;39(1):80–5.CrossRefGoogle ScholarPubMed
21. Kozlov, G, Denisov, AY, Girard, M, et al. Structural basis of defects in the sacsin HEPN domain responsible for autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). J Biol Chem. 2011 Jun 10;286(23):20407–12.CrossRefGoogle ScholarPubMed
22. Parfitt, DA, Michael, GJ, Vermeulen, EG, et al. The ataxia protein sacsin is a functional co-chaperone that protects against polyglutamine-expanded ataxin-1. Hum Mol Genet. 2009;18:1556–65.CrossRefGoogle ScholarPubMed
23. Anderson, JF, Siller, E, Barral, JM. The sacsin repeating region (SRR): a novel Hsp90-related supra-domain associated with neurodegeneration. J Mol Biol. 2010;400:665–74.CrossRefGoogle ScholarPubMed
24. Anderson, JF, Siller, E, Barral, JM. The neurodegenerative disease related protein sacsin is a molecular chaperone. J Mol Biol. 2011 Aug 26;411(4):870–80.CrossRefGoogle ScholarPubMed
25. Girard, M, Larivière, R, Parfitt, DA, et al. Mitochondrial dysfunction and Purkinje cell loss in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1661–6. Epub 2012 Jan 17.CrossRefGoogle ScholarPubMed
26. Schon, EA, Przedborski, S. Mitochondria: the next (neurode) generation. Neuron. 2011;70:1033–53.CrossRefGoogle ScholarPubMed